Benchmark Holdings Plc

AGM Information • Feb 16, 2023

National Storage Mechanism | Additional information

RNS Number : 2128Q

Benchmark Holdings PLC

16 February 2023

16 February 2023

Benchmark Holdings plc

("Benchmark" or the "Company")

Result of AGM

Benchmark Holdings plc, the aquaculture health, nutrition and genetics business, announces that at the Company's Annual General Meeting, held at 3.00 p.m. today, with the exception of Resolutions 15 and 16, all resolutions were passed by shareholders voting on a poll. The results of the poll are set out below.

Res No.	Resolution Name	Votes For	%	Votes Against	%	Votes Total	% I.S.C.	Votes Withheld
01	Reports and accounts	574,934,271	100.00%	8,379	0.00%	574,942,650	77.77	2,000
02	Remuneration Report	572,004,635	99.49%	2,938,015	0.51%	574,942,650	77.77	2,000
03	Reappoint Auditors	573,033,919	99.67%	1,908,731	0.33%	574,942,650	77.77	2,000
04	Auditors remuneration	574,925,589	100.00%	13,311	0.00%	574,938,900	77.77	5,750
05	Trond Williksen	574,934,271	100.00%	8,379	0.00%	574,942,650	77.77	2,000
06	Kristian Eikre	573,072,601	99.67%	1,870,049	0.33%	574,942,650	77.77	2,000
07	Septima Maguire	574,934,271	100.00%	8,379	0.00%	574,942,650	77.77	2,000
08	Peter George	571,410,678	99.39%	3,521,323	0.61%	574,932,001	77.77	12,649
09	Kevin Quinn	574,934,271	100.00%	8,379	0.00%	574,942,650	77.77	2,000
10	Susan Searle	573,072,601	99.67%	1,870,049	0.33%	574,942,650	77.77	2,000
11	Yngve Myhre	574,934,271	100.00%	8,379	0.00%	574,942,650	77.77	2,000
12	Atle Eide	573,068,851	99.67%	1,870,049	0.33%	574,938,900	77.77	5,750
13	Laura Lavers	573,068,851	99.67%	1,870,049	0.33%	574,938,900	77.77	5,750
14	Allot shares	571,916,971	99.47%	3,025,679	0.53%	574,942,650	77.77	2,000
15	pre-emption rights	258,462,999	44.95%	316,479,651	55.05%	574,942,650	77.77	2,000
16	Additional pre-emption rights	255,447,999	44.43%	319,494,651	55.57%	574,942,650	77.77	2,000
17	Purchase own shares	572,977,997	99.67%	1,898,423	0.33%	574,876,420	77.76	68,230
18	Cancel share premium account	574,935,897	100.00%	6,753	0.00%	574,942,650	77.77	2,000

The Board notes that Resolutions 15 (Disapplication of Pre-emption Rights - General) and 16 (Disapplication of Pre-emption Rights - Acquisitions and Specified Capital Investments), which were special resolutions requiring a 75% majority, did not receive sufficient support to be passed.

These resolutions were in line with the updated Pre-Emption Group's Statement of Principles and the Board considers the flexibility afforded by these authorities to be in the best interests of the Company.  In accordance with Provision 4 of the UK Corporate Governance Code, the Board confirms that it will consult and continue to engage with the relevant shareholders to understand and discuss their concerns with respect to these resolutions.

Enquiries

For further information, please contact:
Benchmark Holdings plc	Tel:  0114 240 9939
Ivonne Cantu, Investor Relations
Numis (Broker and NOMAD)	Tel:  020 7260 1000
James Black, Freddie Barnfield, Duncan Monteith
MHP	Tel: 020 3128 8004
Katie Hunt, Reg Hoare, Veronica Farah	benchmark@mhpgroup.com

About Benchmark

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering mission-critical products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare. Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark addresses the major aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all the aquaculture regions around the world.

Find out more at www.benchmarkplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGUNRWROAUUAAR